Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
L'Encephale
|
January 1, 1979
[Mental disorders and prolactin secretion]
C Kordon, M Ruberg
Clinical Neuropharmacology
|
June 15, 1999
Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseases
P P Michel, N Lambeng, M Ruberg
Journal of Neurochemistry
|
November 5, 1997
Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside
P P Michel, M Ruberg, Y Agid
Brain Research
|
November 26, 1984
Adrenergic receptors in Parkinson's disease
R Cash, M Ruberg, R Raisman, et al.
European Journal of Pharmacology
|
February 5, 1985
Adrenergic receptors in frontal cortex in human brain
R Cash, R Raisman, M Ruberg, et al.
Neuroscience Letters
|
December 21, 2000
The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor
N Lambeng, P P Michel, Y Agid, et al.
Brain Research
|
January 28, 1982
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia
M Ruberg, A Ploska, F Javoy-Agid, et al.
Journal of Neurochemistry
|
February 1, 1996
Ceramide induces apoptosis in cultured mesencephalic neurons
B Brugg, P P Michel, Y Agid, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movements
Y Agid, A M Bonnet, M Ruberg, et al.
Journal De Physiologie
|
July 1, 1980
[Effect of neuropeptides on prolactin secretion by the adenohypophysis (author's transl)]
A Enjalbert, S Arancibia, M Ruberg, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
L'Encephale
|
January 1, 1979
[Mental disorders and prolactin secretion]
C Kordon, M Ruberg
Clinical Neuropharmacology
|
June 15, 1999
Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseases
P P Michel, N Lambeng, M Ruberg
Journal of Neurochemistry
|
November 5, 1997
Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside
P P Michel, M Ruberg, Y Agid
Brain Research
|
November 26, 1984
Adrenergic receptors in Parkinson's disease
R Cash, M Ruberg, R Raisman, et al.
European Journal of Pharmacology
|
February 5, 1985
Adrenergic receptors in frontal cortex in human brain
R Cash, R Raisman, M Ruberg, et al.
Neuroscience Letters
|
December 21, 2000
The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor
N Lambeng, P P Michel, Y Agid, et al.
Brain Research
|
January 28, 1982
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia
M Ruberg, A Ploska, F Javoy-Agid, et al.
Journal of Neurochemistry
|
February 1, 1996
Ceramide induces apoptosis in cultured mesencephalic neurons
B Brugg, P P Michel, Y Agid, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movements
Y Agid, A M Bonnet, M Ruberg, et al.
Journal De Physiologie
|
July 1, 1980
[Effect of neuropeptides on prolactin secretion by the adenohypophysis (author's transl)]
A Enjalbert, S Arancibia, M Ruberg, et al.
Page
of 9